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Factors controlling the rate of oxidation of succinate were studied in mitochon- 
dria isolated from twenty-seven specimens of normal human liver obtained at opera- 
tion. These were compared with mitochondria prepared from the livers of anes- 
thetized and unanesthetized rats. Previously reported lower rates of succinate 
oxidation by human liver mitochondria were confirmed. This difference was no 
longer apparent when the succinic dehydrogenase activities of mitochondrial ace- 
tone powders were compared. The apparent. K, o f succinate for human liver mito- 
chondrial succinoxidase is less than that of the anesthetized and unanesthetized rat. 
The concentration of oxalacetate is greater in human liver mitochondria compared 
with the anesthetized and unanesthetized rat. In both aerobic- and cyanide-in- 
hibited mitochondria, the extent of the apparent succinate linked reduction of 
mitochondrial pyridine nucleot,ide was less in man than in the rat. In aerobic rat 
liver mitochondria, anesthesia lowers the extent of succinate-linked pyridine nu- 
cleotide reduction. 
Previous work from this laborat,ory has 
shown that the rate of succinate oxidation 
by human liver mitochrondria is about one 
third of that, found in the rat. This investi- 
gation was designed t’o compare some factors 
which determine succinate oxidation in man 
and rat, in an attempt to determine the 
the cause of this species difference and t.o 
study a possible effect of anesthesia on the 
oxidation of succinate. 
METHODS 
The collection of the liver biopsy specimens, the 
anaesthetics used, the preparation of the mito- 
chondria, the polarographic determination of 
oxygen consumption, t,he assay of proteins and 
the preparation of mitochondrial extracts for 
fluorometric assay were performed as described 
in the earlier publication (1). Twenty-seven 
specimens of human liver were studied. Male, 
Sprague Dawley, albino rats were studied for 
1 This study was supported in part by grant 
AM-07361-2 from the U. S. Public Health Service. 
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Research Career Development Award AM-KS- 
14,030. 
comparison and as controls for the possible ef- 
fects of anesthesia. Where indicated in the text, 
these rats had been anesthetized with ether for 
1 hour prior to sacrifice. 
For the measurement of succinic dehydrogenase 
activity (2)s mitochondrial powders were prepared 
by precipitation and homogenization in a mini- 
mum of twenty-five volumes of acetone at -10°C. 
The precipitate was collected in a Buchner funnel 
and rehomogenized in 0.3 M phosphate buffer, 
pH 7.6. Enzyme activity was measured polaro- 
graphically by the method of Singer and Kearney 
(3), phenazine methosulfate was used as the elec- 
tron acceptor. Maximal enzyme activities were 
calculatjed from a series of measurements accord- 
ing to Lineweaver and Burk (4). 
3 In agreement with the nomenclature intro- 
duced by Keilin and Hartree (2), the term “suc- 
cinoxidase” denotes the enzyme system capable 
of oxidizing succinate in the presence of molecular 
oxygen. The term “succinic dehydrogenase” 
denotes the enzyme system capable of oxidizing 
succinate in the presence of molecular oxygen 
with an artificial electron acceptor such as phena- 
zine methosulfate being interposed between the 
enzyme and molecular oxygen, thus bypassing 
part of the electron transport chain. 
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FIG. 1. Inhibition of oxidation of succinate by 
oxalacetate. Human liver mitochondria (specimen 
I). Medium as in Ref. (1). Italicized figures repre- 
sent rates of oxygen consumption (Fatoms/hour). 
For the determination of the maximal velocities 
of su&iriate oxidation, of the apparent K, for 
succiti’atd ‘and the apparent Ki for oxalacetate, 
mitochondria were incubated with isotonic 
medium (111, pH 7.2, sodium succinate in a final 
concentration of between 1.64 and 0.205 mM, fol- 
lowed by 1.6 mM ADP.4 When a steady state of 
oxygen consumption had been established, the 
medium was made 1 mM in freshly prepared ox- 
alacetate solution and the new and lower rate of 
oxygen consumption recorded (Fig. 1). Plots of 
the reciprocal of succinate concentration against 
the reciprocal of the rate of oxygen uptake gave 
the expected pattern of competitive inhibition of 
succinate by oxalacetate (5) (Fig. 2). The Km and 
Kc values were calculated from the regression 
lines. 
The order of addition of mitochondria, sub- 
strates and phosphate acceptor has been selected 
to show that each specimen showed evidence of 
respiratory control, i.e., an increase in the rate of 
respiration on the addition of ADP to the medium 
containing ,succinate. This precluded measurement 
of the rate of endogenous respiration with ADP 
in the absence of succinate. 
4 Abbreviations used: ADP, adenosine diphos- 
phate; ATP, adenosine triphosphate; EDTA, 
ethylenediaminetetracetate (disodium salt) ; 
LDH, lactic acid dehydrogenase; MDH, malic acid 
dehydrogenase; NAD, nicotinamide adenine 
dinucleot,ide; NADH, reduced nicotinamide ade- 
nine dinucleotide; OAA, oxalacetate; PCA, per- 
chloric acid; PN, pyridine nacleotide; TRAP, 
triethanolamine hydrochloride. 
For the estimation of succinate induced reduc- 
tion of mitochondrial pyridine nucleotides, the 
Eppendorf fluorometer with amplifier and re- 
corder described by Estabrook (6) was used. Mito- 
chondria containing 2-10 mg of protein were 
added to 2.85 ml of 0.25 M sucrose, 10 mM TRAP 
buffer pH 7.2, and 1 mM EDTA. When the medium 
was made 8 mM in acetoacetate (prepared as 
described by Krebs and Eggleston (7), the reduced 
pyridine nucleotides were gradually oxidized un- 
til a steady state was reached. Upon the addition 
of succinate in 4.1 mM final concentration, an 
increase in fluorescence representing pyridine 
nucleotide reduction was recorded. For the meas- 
urement of pyridine nucleotide reduction in termi- 
nally inhibited mitochondria, 1.5 mM potassium 
cyanide was present in the medium before the 
addition of the mitochondria. In view of the need 
for an added source of energy under these condi- 
tions (8), ATP (4.1 mM final concentration) was 
added after t*he succinat#e (Fig. 3). Each incuba- 
tion mixture was calibrated by the addition of a 
small volume of NADH of known optical density 
to a colloidal solution of equivalent background 
fluorescence (e.g., dilute milk). 
For the,estimation of oxalacetate, mitochondria 
were added to four volumes of chilled 6y0 PCA, 
and the mixture thoroughly homogenized in the 
cold. The extract was then neutralized to methyl 
orange with 5 ii/l potassium carbonate. Since such 
a neutralized PCA extract contains malic dehy- 
drogenase (9), oxalacetate was converted to pyrll- 
vate by heating for 30 minutes at 70°C. The heated 
extract was recentrifuged and made to a known 
volume with 0.2 M TRAP buffer, pH 7.6. The 
concentration of pyruvate was then determined 
fluorimetrically with lactic dehydrogenase and 
NADH 
RESULTS 
Oxalacetate was converted quantitatively 
to pyruvate in 30 minutes at 70°C (Table 
I). As measured by us, the apparent concen- 
t’ration of oxalacetate represents the sum of 
the concentrations of oxalacetate and pyru- 
vate. There are, however, a number of rea- 
sons which suggest that the original concen- 
tration of the latter is low or negligible. 
1. Pyruvate is considered to be a repre- 
sentative of the extramitochondrial portion 
of the cell (9). 
2. While, in both human and rat liver 
mit’ochondria, between 30 and 45% of the 
apparent concentration of oxalacetate was 
already present as pyruvate when the heat- 
ing step was omitted, it appeared likely that 
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FIG. 2. Competitive inhibition of succinate oxidation by oxalacetate. Human liver 
mitochondria (specimen 2); 6.56 mg of protein, final volume 3.0 ml. (O-O) 1 mM OAA 
present; (0 -0) OAA absent. 
FIG. 3. Succinate linked pyridine nucleotide reduction. Human liver mitochondria 
(specimen 3). For experimental details see text. 
this pyruvate had been formed by decar- protein per minute. While this is presumably 
boxylation of mitochondrial oxalacetate. a maximal rate it accounts adequately for 
This was support’ed by experiments in which the very small quantities of pyruvate formed 
mitochondria were incubated with added during the isolation of the mit,ochondria. 
oxalacetate in ice, for a period of one hour. 3. Other possible precursors of pyruvate 
Under these conditions pyruvate was formed such as phosphoenol pyruvate or malate 
at, a rate of 0.30-0.40 mpmole per milligram were not converted to pyruvate by the pro- 
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cedure of extraction iyith acid, neutraliza- 
tion and ‘heat’ing and in the absence of tissue 
components. 
The result’s of the. experiments are sum- 
marized in Table II. 
DISCUSSION 
The previously reported differences in t,he 
rates of sucoinate oxidation between human 
and rat liver were confirmed by the calcu- 
TABLE I 




heating (min) After MDH After LDH Difference plus MDH due to LDH 
0 0.736 0.740 0.004 
10 0.197 0.741 0.544 
20 0.026 0.738 0.712 
30 0.010 0.738 0.728 
40 0.011 0.744 0.733 
a A solution of oxalacetate (approximately 
0.40 pmolelml) was heated at 70°C for the periods 
of time stat#ed. One-ml aliquots were then assayed 
in 0.067 M phosphate buffer (pH 7.5) with NADH 
and enzymes as indicated at, 340 rn.u. Final volume, 
3.0 ml. 
lated maximal velocities shown in Table 
II. This confirms t’hat the substrate concen- 
trat,ions used in the previously reported ex- 
periments were near-optimal, and well in 
excess of the apparent K, ,for both human 
and rat liver mitochondria. Indeed t.he ap- 
parent K, of human liver mitochondria was 
significantly lower (P < 0.01) compared 
with the anest’hetized and unanesthetized 
rat. There was no significant difference in 
the apparent, Ki’s between the three groups 
of specimens. The Ki’s were, however, much 
higher than those previously reported by 
Pardee and Potter (5). Their classical st’ud- 
ies were carried out on whole tissue homoge- 
nates whereas in our experiments isolated 
mitochondria were used. There were nu- 
merous other differences in experiment al 
conditions. 
When mitochondrial structure was de- 
stroyed by t’reatment wit’h ice-cold acetone 
in a Waring Blendor and the activity of 
succinic dehydrogenase measured, the spe- 
cies difference in the rate of oxidat#ion of 
succinate is removed, and possibly reversed, 
although the activit,y in the human speci- 
mens showed marked and unexplained vari- 
ability. It seems probable that differences in 
TABLE II 
FACTORS AFFECTING SUCCINATE OXIDATION BY LIVER MITOCHONDRL\ FROM MAN AND RAP 
Maximal velocity batoms O/mg 
prot./hour) 
K, (X 10-3 XV) 
Ki (X lo-” fi1) 
Succinic dehydrogenase Gatoms O/mg 
prot./hour) 
Apparent PN reduction (aerobic) 
(mpmoles/mg protein) 
Apparent ,PN reduction (cyanide 
inhibited) (qmoles/mg protein) 
Concentration of OAA (nqumoles/mg 
protein) 
Mall 
2.41 f 0.41 
(5) 
0.18 f 0.04 
(5) 




29.3, 48.2, 304.8, 
530.8, 16.5, 58.9 
1.34 f 0.33 
(6) 
2.19 f 0.33 
N-5) 
1.00 f 0.27 
(8) 
Anesthetized rat 
7.30 f 0.55 
00) 
0.64 f 0.08 
00) 
0.26 f 0.09 
(10) 
12.00 f 1.84 
(10) 
2.71 zk 0.27 
(10) 
5.62 i 0.52 
(10) 
0.07 i 0.01 
(11) 
Unanesthetized rat 
7.07 f 1.09 
(6) 
1.03 f 0.19 
(11) 
0.38 f 0.12 
(7) 
15.66 i 1.66 
(11) 
4.46 f 0.46 
(11) 
6.40 zk 0.66 
(15) 
0.18 f 0.04 
(12) 
0 All determinations carried out at 25°C. Except where otherwise stated, figures represent means and 
standard error of the mean. Figures in parentheses represent the number of observations. 
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the st,ructure or composition of the acetone 
soluble portion of the mitochondrial mem- 
brane a.re responsible for the observed spe- 
cies differences. 
To explore an alternative pathway of 
succinat’e oxidation, succinate linked reduc- 
tion of pyridine nucleotides was measured. 
In both the aerobic and cyanide inhibited 
states, succinate linked pyridine nucleotide 
reduction was less in human liver mito- 
chondria compared with the aneslhetized 
and unanesthetized rat (p < 0.001). The 
recorded differences in the apparent concen- 
t rations of reduced pyridine nucleotides do 
not, however, represent a rate but a differ- 
ence in two steady states of pyridine nucleo- 
tide reduction. Upon the addit,ion of aceto- 
acetate, an equilibrium 
NADH X Acetoacetate 
NAD X @-Hydroxybutyrate 
is obtained by means of the p-hydroxybu- 
t’yrate dehydrogenase reaction. The addition 
of succinate establishes a new steady state 
because of the increase in NADH resulting 
from succinate linked reduction of pyridine 
nucleotides (10). These experiments were 
carried out in mitochondrial suspensions 
rather than extracts. The pyridine nucleo- 
t,ides were, therefore, presumably bound to 
prot’ein and exhibited fluorescence enhance- 
ment (11). Such fluorescence enhancement 
has been shown by Estabrook to vary from 
a fact’or of four to twelve in rat liver mito- 
chondria under different metabolic condi- 
tions (6). The difference in pyridine nucleo- 
tide reduction between the two steady states 
is t,herefore an indirect represent,ation of the 
actual quantities of pyridine nucleotides re- 
duced. Since these experiments were carried 
out under identical conditions, the data can 
be compared. 
Differences in “reversed oxidation” of 
succinate are not necessarily relevant t’o the 
extent of “forward” oxidation of succinate. 
The documentation of any possible relation- 
ship between “forward” and “reverse” oxi- 
dation would require the measurement of 
succinat#e disappearance. Currently avail- 
able methods do not lend themselves readily 
to the determination of small changes of 
succinate concentrat,ion. 
Attempts were made t*o measure the rate 
of acet>oacetate disappearance in t(he pres- 
ence of succinate using the procedure de- 
scribed by Klingenberg (8). This was feasi- 
ble in both the anesthetized and unanesthe- 
tized rat, but, for unknown reasons, not 
in the three specimens of human liver nutjo- 
chondria where this was att,empted. 
The concemration of oxalacetate, an in- 
hibitor of succinate oxidation (5), was sig- 
nificantly higher in human liver mito- 
chondria compared with the anesthetized 
and unanesthetized rat. (p < 0.01). This 
does not explain the observed species differ- 
ence in the maximal rates of succinat,e oxida- 
tion because, a.s is the case for any competi- 
t’ive inhibitor, again exemplified in Fig. 2, 
the maximal velocity is independent of the 
presence of the inhibitor or its concentration. 
For oxalacetate t’o be an inhibitor under con- 
ditions of less than maximal rates of succi- 
nate oxidation in vivo, would require that 
oxalacetate, tentatively located outside the 
cristae half-membrane by Klingenberg (12) 
would be accessible to the respiratory chain 
dehydrogenases located on the cristae half- 
membrane. Furthermore, and particularly 
for low concentrations of succinate, the 
lower K, of human liver mitochondria for 
succinate might reverse a possible inhibi- 
tory effect’ of oxalacetate. 
Anesthetized rats were studied as an addi- 
tional control to determine whether anes- 
thesia would modify the fact’ors responsible 
for the different rates of succinate oxidation 
in man and rat. The effects of anesthesia 
were clearly less evident than the species 
differences. Anesthesia may have lowered 
the concentration of mitochondrial oxalace- 
t,at,e, but this was of doubt,ful significance 
(O.Oci > p > 0.02). A more striking differ- 
erence was in the aerobic reduction of mito- 
chondrial pyridine nucleotides. This was 
lowered in the anesthetized compared with 
t’he normal rate (p < O.Ol), and is an aspect 
of the metabolic effects of anesthetics which 
deserves further st)udy. 
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